News Summary: Congress probes meningitis outbreak

Published



CALL FOR CLARITY: The head of the Food and Drug Administration asked Congress to give her agency greater authority over compounding pharmacies, at the first hearing to examine a deadly meningitis outbreak tied to contaminated steroid injections.

REPUBLICAN PUSHBACK: Republicans on the House Energy and Commerce Committee asked FDA Commissioner Margaret Hamburg why her agency didn’t act sooner to stop the Massachusetts pharmacy linked to the outbreak, which has killed 32 Americans.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.